Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Adenosine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A known ✓ | P29274 | 3/20 | 0.61 |
| ▸ | ADORA2B known ✓ | P29275 | 3/20 | 0.61 |
| ▸ | ADORA3 known ✓ | P0DMS8 | 2/20 | 0.61 |
| ▸ | ADORA1 known ✓ | P30542 | 2/20 | 0.61 |
| ▸ | INMT | O95050 | 4/20 | 0.61 |
| ▸ | DOT1L | Q8TEK3 | 4/20 | 0.60 |
| ▸ | DPP4 | P27487 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.60 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.60 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.60 |
| ▸ | GAPDH | P04406 | 1/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.60 |
| ▸ | STAT6 | P42226 | 1/20 | 0.60 |
| ▸ | PI4KA | P42356 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.60 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.60 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.60 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Adenosine SCHEMBL225271 | 1.00 | INMT (0.61) | INMTADORA2AADORA2BADORA3ADORA1 | |
| Adenosine SCHEMBL28133223 | 0.99 | INMT (0.63) | INMTADORA2AADORA2BADORA3ADORA1 | |
| Inosine SCHEMBL8836252 | 0.92 | ADORA2A (0.55) | INMTADORA2AADORA2BADORA3ADORA1 | |
| Adenosine Phosphate SCHEMBL2037385 | 0.89 | P2RY1 (0.65) | INMTADORA1SMN1; SMN2 | |
| Adenosine Phosphate SCHEMBL15670577 | 0.89 | P2RY1 (0.65) | INMTADORA1SMN1; SMN2 | |
| SCHEMBL11772880 | 0.89 | MARS1 (0.62) | INMTADORA2AADORA2BADORA3ADORA1 | |
| SCHEMBL225270 | 0.89 | MARS1 (0.62) | INMTADORA2AADORA2BADORA3ADORA1 | |
| Guanosine SCHEMBL11034252 | 0.86 | HINT1 (0.66) | ADORA2AADORA2BADORA3ADORA1 | |
| SCHEMBL21067651 | 0.84 | P2RY1 (0.60) | INMTADORA1SMN1; SMN2 | |
| Adenosine Phosphate SCHEMBL15670433 | 0.84 | P2RY1 (0.58) | INMTADORA1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2740499-B1 | ANTI-ADHESION MEDICAL MATERIAL AND METHOD FOR PRODUCING SAME | DAINICHISEIKA COLOR CHEM (JP) | 2018-09-26 | — | — | EP | disclosed |
| CN-106467743-B | The gold nanoclusters and its preparation method and application of high temperature resistant luminescence enhancement | 东南大学 | 2018-09-21 | — | — | CN | disclosed |
| CN-106467743-A | Gold nanoclusters of high temperature resistant luminescence enhancement and its preparation method and application | 东南大学 | 2017-03-01 | — | — | CN | disclosed |
| CN-103732265-B | Anti medical material and manufacture method thereof | 大日精化工业株式会社 | 2016-10-12 | — | — | CN | disclosed |
| EP-2740499-A1 | ANTI-ADHESION MEDICAL MATERIAL AND METHOD FOR PRODUCING SAME | Dainichiseika Color & Chemicals Mfg. Co., Ltd. (JP) | 2014-06-11 | — | — | EP | disclosed |
| US-20140112972-A1 | ANTI-ADHESION MEDICAL MATERIAL AND METHOD FOR PRODUCING SAME | DAINICHISEIKA COLOR & CHEMICALS MFG. CO., LTD. (JP) | 2014-04-24 | — | — | US | disclosed |
| CN-103732265-A | Anti-adhesion medical material and method for producing same | DAINICHISEIKA COLOR CHEM | 2014-04-16 | — | — | CN | disclosed |
| US-20130230637-A1 | MEDICAL MATERIAL FOR IN VIVO IMPLANTATION CONTAINING SOFTENING AGENT AND OR MOISTURIZING AGENT, METHOD FOR CONTROLLING CONTENT OF SOFTENING AGENT AND OR MOISTURIZING AGENT IN THE MEDICAL MATERIAL, AND METHOD FOR PRODUCING THE MEDICAL MATERIAL FOR IN VIVO IMPLANTATION | NOISHIKI YASUHARU (JP) | 2013-09-05 | — | — | US | disclosed |
| US-20130230636-A1 | MEDICAL MATERIAL FOR IN VIVO IMPLANTATION CONTAINING SOFTENING AGENT AND OR MOISTURIZING AGENT, METHOD FOR CONTROLLING CONTENT OF SOFTENING AGENT AND OR MOISTURIZING AGENT IN THE MEDICAL MATERIAL, AND METHOD FOR PRODUCING THE MEDICAL MATERIAL FOR IN VIVO IMPLANTATION | NOISHIKI YASUHARU (JP) | 2013-09-05 | — | — | US | disclosed |
| US-20130230638-A1 | MEDICAL MATERIAL FOR IN VIVO IMPLANTATION CONTAINING SOFTENING AGENT AND/OR MOISTURIZING AGENT, METHOD FOR CONTROLLING CONTENT OF SOFTENING AGENT AND/OR MOISTURIZING AGENT IN THE MEDICAL MATERIAL, AND METHOD FOR PRODUCING THE MEDICAL MATERIAL FOR IN VIVO IMPLANTATION | NOISHIKI YASUHARU (JP) | 2013-09-05 | — | — | US | disclosed |
| EP-2417989-A1 | MEDICAL MATERIAL FOR IN VIVO IMPLANTATION CONTAINING SOFTENING AGENT AND/OR MOISTURIZING AGENT , METHOD FOR CONTROLLING CONTENT OF SOFTENING AGENT AND/OR MOISTURIZING AGENT IN THE MEDICAL MATERIAL, AND METHOD FOR PRODUCING THE MEDICAL MATERIAL FOR IN VIVO IMPLANTATION | NICEM LTD (JP) | 2012-02-15 | — | — | EP | disclosed |
| US-20120004673-A1 | MEDICAL MATERIAL FOR IN VIVO IMPLANTATION CONTAINING SOFTENING AGENT AND/OR MOISTURIZING AGENT, METHOD FOR CONTROLLING CONTENT OF SOFTENING AGENT AND/OR MOISTURIZING AGENT IN THE MEDICAL MATERIAL, AND METHOD FOR PRODUCING THE MEDICAL MATERIAL FOR IN VIVO IMPLANTATION | NICEM LTD. (JP) | 2012-01-05 | — | — | US | disclosed |